Compound 150 displayed antiproliferative activity in MYC-driven cancer cells with GI50 values of 0.26, 0.49, 0.24, 1.2, 0.58, and 3.2 μM against CHP-134, Ramos, Raji, Daudi, and SW620 cell lines, respectively, although the MYC expressing human colon cancer cell line SW480 was resistant to treatment with compound 150. This evidence concerns the gene MYC and colonic neoplasm.